WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPDI) today announced it has been chosen as a preferred provider to a consortium of 14 global health Product Development Partners (PDPs) to bring safe, new medicines to the developing world. PPD will have the opportunity to work closely with the PDPs to deliver global clinical research and development services that advance global health in the world’s poorest countries.
